Global Longitudinal Strain Score Predicts Subclinical Cardiac Involvement of Multiple Sclerosis Patients

Overview

Journal Neurol Sci

Specialty Neurology

Date 2025 Feb 15

PMID 39954100

Authors

Fidel Demir

Mehmet Ozbek

Mehmet Ata Akil

Esref Akil

Affiliations

Soon will be listed here.

Abstract

Background: People with multiple sclerosis (MS) have a higher risk of cardiovascular disease than the general population, but the data are limited. Evaluation with strain echocardiography, a new echocardiographic method, can provide more objective data to evaluate global and segmental left ventricular systolic functions. Left ventricular Global Longitudinal Strain (GLS) may be useful in demonstrating subclinical myocardial dysfunction in MS, therefore we planned such a study. We aim to evaluate LV functions with GLS obtained with basal tissue doppler in people with MS.

Material And Methods: A comparison of the demographic laboratory and echocardiographic findings of the multiple sclerosis patients with strain echocardiography records registered in our hospital and the control group with similar age and gender was performed. 80 RRMS patients and 65 control group were compared. Those with another chronic disease, those who received exacerbation treatment within the last month, those outside the age range of 18-65, and other forms of progressive MS were excluded from the study.

Results: GLS scores was significantly lower in the MS group(-17.05 ± 1.33 vs.18.99 ± 1.08, p < 0.001). The optimal GLS score predicted poor LV functional status in people with MS with high EDSS scores with cut-off value ≤ 17.10, sensitivity of 73%, specificity of 58% [AUC: 0.652 95% CI, (0.531-0.773), p = 0.023]. It was observed that as the EDSS score increased, that is, in the presence of worse clinical condition, the GLS score decreased (r = -0.245, p = 0.003).

Conclusions: We think that strain echocardiography may be useful in demonstrating subclinical myocardial damage in people with MS. We found that as the EDSS score, that is, the severity of the disease, increases, the subclinical effect on cardiac functions increases.

References

Jadidi E, Mohammadi M, Moradi T . High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013; 19(10):1336-40. DOI: 10.1177/1352458513475833. View

McDougall A, McLeod J . Autonomic nervous system function in multiple sclerosis. J Neurol Sci. 2003; 215(1-2):79-85. DOI: 10.1016/s0022-510x(03)00205-3. View

Savci S, Inal-Ince D, Arikan H, Guclu-Gunduz A, Cetisli-Korkmaz N, Armutlu K . Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil. 2005; 27(22):1365-71. DOI: 10.1080/09638280500164479. View

Vita G, Fazio M, MILONE S, Blandino A, Salvi L, Messina C . Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci. 1993; 120(1):82-6. DOI: 10.1016/0022-510x(93)90029-x. View

Abraham T, Dimaano V, Liang H . Role of tissue Doppler and strain echocardiography in current clinical practice. Circulation. 2007; 116(22):2597-609. DOI: 10.1161/CIRCULATIONAHA.106.647172. View

Sahn D, DeMaria A, Kisslo J, Weyman A . Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58(6):1072-83. DOI: 10.1161/01.cir.58.6.1072. View

HEIMDAL A, Stoylen A, TORP H, Skjaerpe T . Real-time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr. 1998; 11(11):1013-9. DOI: 10.1016/s0894-7317(98)70151-8. View

Gilman G, Khandheria B, Hagen M, Abraham T, Seward J, Belohlavek M . Strain rate and strain: a step-by-step approach to image and data acquisition. J Am Soc Echocardiogr. 2004; 17(9):1011-20. DOI: 10.1016/j.echo.2004.04.039. View

Akgul F, McLek I, Duman T, Seyfeli E, Seydaliyeva T, Yalcin F . Subclinical left ventricular dysfunction in multiple sclerosis. Acta Neurol Scand. 2006; 114(2):114-8. DOI: 10.1111/j.1600-0404.2006.00662.x. View

10.

Spindler M, Weilbach F, Beer M, Sandstede J, Kostler H, Strotmann J . Non-invasive functional and biochemical assessment of mitoxantrone cardiotoxicity in patients with multiple sclerosis. J Cardiovasc Pharmacol. 2003; 42(5):680-7. DOI: 10.1097/00005344-200311000-00015. View

11.

Strotmann J, Spindler M, Weilbach F, Gold R, Ertl G, Voelker W . Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone. Am J Cardiol. 2002; 89(10):1222-5. DOI: 10.1016/s0002-9149(02)02312-3. View

12.

Olindo S, Guillon B, Helias J, Phillibert B, Magne C, FEVE J . Decrease in heart ventricular ejection fraction during multiple sclerosis. Eur J Neurol. 2002; 9(3):287-91. DOI: 10.1046/j.1468-1331.2002.00400.x. View

13.

Voigt J, ARNOLD M, Karlsson M, Hubbert L, Kukulski T, Hatle L . Assessment of regional longitudinal myocardial strain rate derived from doppler myocardial imaging indexes in normal and infarcted myocardium. J Am Soc Echocardiogr. 2000; 13(6):588-98. DOI: 10.1067/mje.2000.105631. View

14.

Ohte N, Narita H, Miyabe H, Takada N, Goto T, Mizuno H . Evaluation of whole left ventricular systolic performance and local myocardial systolic function in patients with prior myocardial infarction using global long-axis myocardial strain. Am J Cardiol. 2004; 94(7):929-32. DOI: 10.1016/j.amjcard.2004.06.031. View